<DOC>
	<DOCNO>NCT02851472</DOCNO>
	<brief_summary>The investigator seek determine whether provide inhaled nitric oxide ( iNO ; vasodilator ) improve delivery oxygen brain , kidney intestine preterm neonate subject receives pack red blood cell transfusion ( PRBC ) anemia vs. baseline period . The investigator observe effect inhale nitric oxide vs. placebo body sit determine whether iNO alter fractional tissue oxygen extraction . Treatment control group compare equivalent epochs individual patient , PRBC transfusion .</brief_summary>
	<brief_title>Prevention Transfusion Related Acute Gut Injury ( TRAGI ) Extremely Low Gestational Age Neonates ( ELGANs ) Using iNO</brief_title>
	<detailed_description>Selection criterion : 1 ) Neonates 24 0/7 27 6/7 week gestational age ( GA ) 2 ) More 2 week postnatal age . 3 ) Anemia Hct le 28 % 4 ) &gt; 50 % total daily fluid enteral 5 ) History least 1 prior PRBC transfusion ELGANs admit neonatal intensive care unit ( NICU ) screen study . If patient meet selection criterion , parent approach obtain informed consent . Then patient randomize either iNO placebo group treatment . The treat physician make decision regard time PRBC transfusion treat anemia subject . During period observation , near infrared spectroscopy ( NIRS ) monitoring perform enrolled subject non-invasive probe attach skin 3 site simultaneously- abdomen umbilicus , flank/back , forehead calculation fractional tissue oxygen extraction ( FTOE ) conjunction concurrent pulse oximetry recording . Conventional vital sign , blood gas , lactate , haptoglobin cytokine measure PRBC transfusion</detailed_description>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Neonates 24 0/7 27 6/7 week gestational age More 2 week postnatal age . Anemia hematocrit ( Hct ) less 28 % More 50 % total daily fluid enteral History least 1 prior PRBC transfusion ( preferably donor ) Prior history necrotizing enterocolitis ( NEC ) avoid confounder Clinically significant patent ductus arteriosus ( PDA ) require treatment ( Rx ) within 24h Hypotensive age active bleeding &lt; 50 % total fluids enteral ( breast milk formula ) Major congenital surgical malformation Known chromosomal anomaly detect antepartum test direct physical examination subsequent postnatal laboratory confirmation Absence parental treat physician consent A concurrent randomize clinical trial ( RCT ) another randomize drug Death expect &lt; 48h Another major concern treat physician either mandate prohibits study treatment know adverse reaction prior transfusion ( Tx )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>TRAGI ( transfusion relate acute gut injury )</keyword>
	<keyword>inhale nitric oxide ( iNO )</keyword>
	<keyword>prematurity</keyword>
	<keyword>PRBC transfusion</keyword>
	<keyword>NEC ( necrotizing enterocolitis )</keyword>
	<keyword>NIRS ( near infrared spectroscopy )</keyword>
	<keyword>ELGAN ( extremely low gestational age neonate )</keyword>
</DOC>